Dianthus Therapeutics, Inc. (DNTH) Reports Q3 Loss, Lags Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.97 per share versus the Zacks Consensus Estimate of a loss of$ 0.86. This compares to a loss of $0.74 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -12.79%. A quarter ago, it was expected that this company would post a loss of$ 0.86 per share when it actually produced a loss of $0.88, delivering a surprise of -2.33%.Over the last four quarters, the compa ...